Balzan Silvana, Nicolini Giuseppina, Forini Francesca, Boni Giuseppe, Del Carratore Renata, Nicolini Andrea, Carpi Angelo, Iervasi Giorgio
Institute of Clinical Physiology, CNR, Via Moruzzi 1, Pisa 56124, Italy.
Biomed Pharmacother. 2007 Sep;61(8):463-7. doi: 10.1016/j.biopha.2007.04.009. Epub 2007 May 25.
The presence of thyrotropin receptors (TSHR) has been reported in some extrathyroidal tissues but its physio-pathological role still remains unclear. TSH (seems to) affects the human erythrocytes Na(+)/K(+)-ATPase in vitro, however receptors on erythrocytes have not yet been described. In this work the effect of recombinant human TSH (rhTSH) on sites number and activity of erythrocyte Na(+)/K(+)-ATPase was investigated in a group of thyroidectomized patient enrolled for rhTSH test. As detected by (3)H-ouabain binding, rhTSH administration induced a significant increase in the number of sites (p=0.005) and in the Kd (p=0.006) of Na(+)/K(+)-ATPase. rhTSH did not induce significant difference in Na(+)/K(+)-ATPase activity measured by (86)Rb uptake. (125)I-TSH binding studies and Western blotting data showed the existence of TSHR in the erythrocytes of healthy donors. In conclusion The TSH action on Na(+)/K(+)-ATPase of human erythrocytes can be explained by the presence of TSHR.
已有报道称在一些甲状腺外组织中存在促甲状腺激素受体(TSHR),但其生理病理作用仍不清楚。促甲状腺激素(TSH)在体外似乎会影响人类红细胞的钠钾ATP酶,然而红细胞上的受体尚未被描述。在这项研究中,对一组因重组人促甲状腺激素(rhTSH)检测而入选的甲状腺切除患者,研究了rhTSH对红细胞钠钾ATP酶位点数量和活性的影响。通过³H-哇巴因结合检测发现,给予rhTSH会导致钠钾ATP酶的位点数量(p = 0.005)和解离常数(Kd,p = 0.006)显著增加。通过⁸⁶Rb摄取测量,rhTSH并未导致钠钾ATP酶活性出现显著差异。¹²⁵I-TSH结合研究和蛋白质印迹数据表明健康供体的红细胞中存在TSHR。总之,TSH对人类红细胞钠钾ATP酶的作用可通过TSHR的存在来解释。